[
  {
    "ts": null,
    "headline": "Trading Rotation Kicks Off 2nd Half of 2025",
    "summary": "Tech stocks lagged after a very strong first half of the year, while healthcare led the way.",
    "url": "https://finnhub.io/api/news?id=9f001392d0002986a87586a58bfaf4a7ff645f5ecc55740cb69c6ac029fee036",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751407740,
      "headline": "Trading Rotation Kicks Off 2nd Half of 2025",
      "id": 135699842,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Tech stocks lagged after a very strong first half of the year, while healthcare led the way.",
      "url": "https://finnhub.io/api/news?id=9f001392d0002986a87586a58bfaf4a7ff645f5ecc55740cb69c6ac029fee036"
    }
  },
  {
    "ts": null,
    "headline": "Top 15 High-Growth Dividend Stocks For July 2025",
    "summary": "The Top 15 High-Growth Dividend Stocks for July 2025 boast a 1.38% yield, 18.78% growth rate and 23% undervaluation. Read more analysis here.",
    "url": "https://finnhub.io/api/news?id=db68923c43750f711ee4eb0686c20e0ef46577dda3b952452564eada3f9f2da7",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751403721,
      "headline": "Top 15 High-Growth Dividend Stocks For July 2025",
      "id": 135700685,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2160360708/image_2160360708.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "The Top 15 High-Growth Dividend Stocks for July 2025 boast a 1.38% yield, 18.78% growth rate and 23% undervaluation. Read more analysis here.",
      "url": "https://finnhub.io/api/news?id=db68923c43750f711ee4eb0686c20e0ef46577dda3b952452564eada3f9f2da7"
    }
  },
  {
    "ts": null,
    "headline": "Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?",
    "summary": "Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
    "url": "https://finnhub.io/api/news?id=b44a1069b8d57c9525354c24ec1cb4845a99b08e1a09b06f27cd62e7b95f1151",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751386204,
      "headline": "Will Merck (MRK) Beat Estimates Again in Its Next Earnings Report?",
      "id": 135698021,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "Merck (MRK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.",
      "url": "https://finnhub.io/api/news?id=b44a1069b8d57c9525354c24ec1cb4845a99b08e1a09b06f27cd62e7b95f1151"
    }
  },
  {
    "ts": null,
    "headline": "Top 10 High-Yield Dividend Stocks For July 2025",
    "summary": "Discover July 2025's high-yield stock picks targeting a 12% CAGR. Outperform benchmarks with superior dividends and five-year growth potential. Click to read.",
    "url": "https://finnhub.io/api/news?id=5eda94aec6b6783d0f4b1c25500a8b1d4dbe21f07fb26477592859ab3538d191",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751378798,
      "headline": "Top 10 High-Yield Dividend Stocks For July 2025",
      "id": 135696429,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2188948847/image_2188948847.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Discover July 2025's high-yield stock picks targeting a 12% CAGR. Outperform benchmarks with superior dividends and five-year growth potential. Click to read.",
      "url": "https://finnhub.io/api/news?id=5eda94aec6b6783d0f4b1c25500a8b1d4dbe21f07fb26477592859ab3538d191"
    }
  },
  {
    "ts": null,
    "headline": "Dividend Yield Theory Says Merck Is A Buy",
    "summary": "Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis of MRK stock now.",
    "url": "https://finnhub.io/api/news?id=834f6c41a13ef01ef32430679fea68a13c91eade7633e28e61c1eacc094f648c",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751378260,
      "headline": "Dividend Yield Theory Says Merck Is A Buy",
      "id": 135696430,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2190227480/image_2190227480.jpg?io=getty-c-w1536",
      "related": "MRK",
      "source": "SeekingAlpha",
      "summary": "Merck & Co., Inc.'s 4.09% dividend yield and robust pipeline signal strong growth potential. Click here to read an analysis of MRK stock now.",
      "url": "https://finnhub.io/api/news?id=834f6c41a13ef01ef32430679fea68a13c91eade7633e28e61c1eacc094f648c"
    }
  },
  {
    "ts": null,
    "headline": "Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth",
    "summary": "PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.",
    "url": "https://finnhub.io/api/news?id=46543e5cb151f0452bc391a5dcf849b8d52583641e9c4a220c08a13b1e11baeb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751376900,
      "headline": "Pfizer's Strong Late-Stage Pipeline Can Drive Long-Term Growth",
      "id": 135693585,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.",
      "url": "https://finnhub.io/api/news?id=46543e5cb151f0452bc391a5dcf849b8d52583641e9c4a220c08a13b1e11baeb"
    }
  },
  {
    "ts": null,
    "headline": "Apple’s Biggest Bear Isn’t Budging. Hear Him Out.",
    "summary": "Apple’s Biggest Bear Isn’t Budging. Hear Him Out.",
    "url": "https://finnhub.io/api/news?id=2025011ce8c88f3cc400843cb8ad19836578afc34de2d2abc85088671a29b4aa",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751375460,
      "headline": "Apple’s Biggest Bear Isn’t Budging. Hear Him Out.",
      "id": 135730281,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Apple’s Biggest Bear Isn’t Budging. Hear Him Out.",
      "url": "https://finnhub.io/api/news?id=2025011ce8c88f3cc400843cb8ad19836578afc34de2d2abc85088671a29b4aa"
    }
  },
  {
    "ts": null,
    "headline": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
    "summary": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
    "url": "https://finnhub.io/api/news?id=1c6d3b4186a76d5225de09218dc8bc43210d3a4778efb05914b4baa6e8a50e47",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751372100,
      "headline": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
      "id": 135729841,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow up nearly 500 points on gains in Amgen, Merck stocks",
      "url": "https://finnhub.io/api/news?id=1c6d3b4186a76d5225de09218dc8bc43210d3a4778efb05914b4baa6e8a50e47"
    }
  },
  {
    "ts": null,
    "headline": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
    "summary": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
    "url": "https://finnhub.io/api/news?id=d71523d544b94030d53eb6b87630c8a93b7a7ac763b72501532ba7fd0a8134ed",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751368440,
      "headline": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
      "id": 135729800,
      "image": "",
      "related": "MRK",
      "source": "MarketWatch",
      "summary": "Dow's 300-point rally highlighted by gains in Amgen, Merck shares",
      "url": "https://finnhub.io/api/news?id=d71523d544b94030d53eb6b87630c8a93b7a7ac763b72501532ba7fd0a8134ed"
    }
  },
  {
    "ts": null,
    "headline": "Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29",
    "summary": "RAHWAY, N.J., July 01, 2025--Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29",
    "url": "https://finnhub.io/api/news?id=0c3162bfac60aa3da9542611e9e3d1949de98bb9973b4c17c7601b17821a0085",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1751366700,
      "headline": "Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29",
      "id": 135691507,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRK",
      "source": "Yahoo",
      "summary": "RAHWAY, N.J., July 01, 2025--Merck to Hold Second-Quarter 2025 Sales and Earnings Conference Call July 29",
      "url": "https://finnhub.io/api/news?id=0c3162bfac60aa3da9542611e9e3d1949de98bb9973b4c17c7601b17821a0085"
    }
  }
]